• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’

by March 21, 2025
written by March 21, 2025

Rep. Marjorie Taylor Greene, R-Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs ‘are causing permanent harm and deaths.’

‘FDA approval for COVID-19 vaccines needs to be pulled and they need taken off the childhood vaccine schedule ASAP,’ she said Thursday in a post on X. ‘I’ve been saying this ever since they were created and my personal Twitter account was permanently banned for my outspoken stance against the vaccines until Elon Musk bought Twitter, changed it to X, and restored my account along with thousands of people who were censored and silenced.’

The child and adolescent immunization schedule on the Centers for Disease Control and Prevention website includes COVID-19 vaccine recommendations for children 6 months old and above.

Greene contends that the jabs should never have been approved in the first place.

‘COVID-19 vaccines should have never received approval and they’ve known the entire time how bad the side effects are and deaths caused by them. It’s time to do the right thing. Stop the COVID-19 vaccines,’ she declared in her post.

But the CDC notes, ‘COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is currently no FDA-approved or FDA-authorized COVID-19 vaccine for children younger than age 6 months. CDC recommends that people stay up to date with COVID-19 vaccination.’

‘Cases of myocarditis and pericarditis have rarely been observed following receipt of COVID-19 vaccines used in the United States,’ the CDC indicates.

‘Evidence from multiple monitoring systems support a causal association for mRNA COVID-19 vaccines (Moderna or Pfizer-BioNTech) and myocarditis and pericarditis. Cases have occurred most frequently in adolescent and young adult males within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Moderna and Pfizer-BioNTech); however, cases have also been observed in females and after other doses.’

Rep. Thomas Massie has also expressed the view that the FDA should nix approval for the COVID-19 vaccines. 

‘FDA should immediately revoke approval of these shots,’ he tweeted last month.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump warns of jail time for Tesla vandals, anyone funding the attacks: ‘WE ARE LOOKING FOR YOU!!!’
next post
Trump’s hostage envoy Boehler met with Taliban in Kabul in first in-person meeting since takeover

related articles

Justice Jackson accuses Supreme Court of ensuring Trump...

August 22, 2025

Trump–Bolton feud back in focus after FBI raid:...

August 22, 2025

John Bolton blasted by Trump ally Roger Stone,...

August 22, 2025

James Comer praises Kash Patel for ‘holding deep...

August 22, 2025

Trump DOJ to begin handing over Epstein files...

August 22, 2025

TikTok isn’t enough to stop Gen Z from...

August 22, 2025

Trump administration wins Supreme Court fight to slash...

August 22, 2025

Zelenskyy seeks ‘strong reaction’ from US if Putin...

August 22, 2025

Pentagon unveils new medal for troops deployed in...

August 21, 2025

Federal judge rules Trump appointee Alina Habba is...

August 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • JetBlue talking to ‘multiple airlines’ about a new partnership

    February 20, 2025
  • Homesick GOP senators mull throwing out the rules over stonewalling Dems

    July 31, 2025
  • Retailers shift their thinking on delivery as consumer need for speed raises costs

    July 25, 2024
  • Biden says ‘The choice is up to you, the American people’ while saying he won’t seek re-election

    July 25, 2024
  • ABOS Stock: Can Acumen’s Alzheimer’s Drug Boost the Stock?

    August 19, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,789)
  • Investing (634)
  • Stock (894)

Latest Posts

  • The dollar index is losing ground below support at 104.00

    July 17, 2024
  • Biden chief of staff reportedly gave approval for autopen pardons on final day in office

    July 14, 2025
  • Trump admin cracks down on groups tied to Iran targeting US citizens, sanctions Iranian-linked Swedish gang

    March 14, 2025

Recent Posts

  • Fox News Poll: Obama, RFK Jr., and Taylor Swift more popular than Harris, Trump

    October 17, 2024
  • GOP rebels go to war over Biden’s mammoth $98B disaster aid request

    December 5, 2024
  • With 28 days until voting starts, ‘election season’ kicks off sooner than you think

    August 9, 2024

Editor’s Pick

  • National security advisor says Putin, Zelenskyy agree ‘only President Trump could get them to the table’

    February 16, 2025
  • A tricky start to 2025

    January 9, 2025
  • DAVID MARCUS: Time for Trump to make a real estate deal for Greenland

    March 29, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock